18 SCI Papers. 8 RCTs. 5 Hospital Partners. One National Standard.
Key Takeaways
18
SCI Publications
Peer-Reviewed
8
RCT Trials
1,200+ Participants
5
Hospital Partners
Grade-A Tertiary
1
National Standard
Lead Drafter
Across 8 peer-reviewed trials spanning comfort, metabolic function, and immune cell activity.
Comfort & Mobility
Level 3 · Human Clinical Research78%
of participants reported meaningful comfort improvement
Comfort scores (VAS) showed significant improvement over a standard 8-week application protocol, with sustained results at 4-week follow-up.
— RCT 2024-CP-001
Metabolic Function
Level 3 · Human Clinical Research63%
improvement in triglyceride metabolism markers
AMPK pathway activation biomarkers showed significant upregulation after 12 weeks of regular application, indicating enhanced metabolic efficiency.
— RCT 2024-MB-003
Immune Cell Activity
Level 3 · Human Clinical Research42%
increase in CD3+ T-cell activity markers observed
Post-application flow cytometry revealed changes in T-cell metabolic dynamics, suggesting areas for further investigation.
— RCT 2024-IM-005
Why XIHE Supports Every Modality
In modern wellness and clinical practice, precision interventions — PEMF technology, micro-hyperbaric oxygen chambers, CoQ10 supplementation — are the "scalpel." They address specific physiological targets with precision.
But a scalpel needs fertile ground. The cellular energy environment is the "soil."
XIHE provides a constant Environmental Layer — optimizing cellular metabolism, enhancing mitochondrial ATP production, and creating the fertile microenvironment where recovery interventions take root.
Published research suggests this synergistic approach can amplify measured outcomes by up to 30% when combined with targeted wellness modalities.
18 SCI-indexed publications advancing the science of graphene far-infrared resonance.
Graphene Far-Infrared Effects on Cellular Stress Pathways
Laboratory research investigated the interaction of far-infrared radiation from graphene materials with cellular stress responses in an in vitro model.
Zhang L. et al.UCP1 Activation Through Graphene Far-Infrared Resonance
Research observed that graphene far-infrared resonance is associated with UCP1 protein expression changes, trending toward improved metabolic markers.
Wang X. et al.Far-Infrared and Mitochondrial Function
Research observed that far-infrared radiation is associated with changes in mitochondrial function and ATP synthesis via cytochrome c oxidase.
Hsu Y.H. et al.Anti-Inflammatory Effects of Photobiomodulation
Comprehensive review of the anti-inflammatory mechanisms of photobiomodulation, contributing to the theoretical foundation for far-infrared resonance research.
Hamblin M.R. et al.Complete library of 34 references available upon request from XIHE B2B Division.
Research validation across 5 Grade-A tertiary hospitals.
Rehabilitation medicine & comfort research
Metabolic & endocrine research
Immunology & oncology supportive care
Physical rehabilitation & sports medicine
Microcirculation & vascular health
Each partnership involves structured research investigation protocols, with XIHE technology integrated into specific departments for targeted outcome measurement.
300+
Participants enrolled across active research studies
12
Research protocols in active or pending status
National leadership in graphene electrothermal technology.
Industry Standard
#1 Standard Drafter
Lead drafter of China's "Graphene Flexible Electrothermal Film" industry standard — a national-level recognition of XIHE's technical authority.
Standard No. 2024-0923T-YB
Strategic Partnership
55% IKKEM Stake
Joint-equity partnership with the national-level advanced materials innovation platform, securing XIHE's position at the frontier of graphene R&D.
Jiageng Innovation Laboratory
Intellectual Property
40+ Patents
XIHE holds 40+ core patents in graphene composite materials, far-infrared resonance technology, and precision thermal control systems.
Quality Certification
ISO 13485
Quality management system certification reflecting XIHE's commitment to rigorous manufacturing and process standards.
What does published research say about far infrared graphene technology?
Published research spanning 18 SCI-indexed publications and 8 randomized controlled trials has investigated the effects of 5-15um far infrared graphene technology. Studies have observed changes in comfort scores, microcirculation parameters, and metabolic markers across multiple research domains.
How many studies have evaluated far infrared graphene technology?
XIHE's far infrared graphene platform has been investigated in 8 randomized controlled trials involving over 1,200 participants, supported by 18 peer-reviewed SCI publications. Research partners include Peking University Third Hospital, Xiamen University Affiliated Hospital, and other Grade-A tertiary institutions.
What outcomes have been observed in far infrared graphene studies?
Published studies have reported measurable changes in comfort and mobility outcomes (78.3%), metabolic function markers (63%), and immune cell activity parameters (42% CD3+ observation). Research suggests these observations are associated with photobiomodulation — the interaction of specific light wavelengths with mitochondrial enzymes.
What types of facilities use far infrared graphene technology?
XIHE far infrared graphene systems are deployed across professional recovery facilities, longevity and wellness clinics, sports performance centers, rehabilitation environments, and home wellness settings. The technology platform supports applications ranging from full-body professional systems to portable personal devices.
The evidence base for far infrared graphene resonance technology continues to grow. XIHE invites research partners to contribute to the next chapter of this investigation.